Diagnosis of Early Alzheimer’s Disease: Clinical Practice in 2021 von Porsteinsson, A. P., Isaacson, R. S., Knox, Sean, Sabbagh, M. N., Rubino, I.

Volltext

Quantitative EEG as a predictive biomarker for Parkinson disease dementia von KLASSEN, B. T, HENTZ, J. G, SHILL, H. A, DRIVER-DUNCKLEY, E, EVIDENTE, V. G. H, SABBAGH, M. N, ADLER, C. H, CAVINESS, J. N

Volltext

Impact of Beta-Amyloid-Specific Florbetaben PET Imaging on Confidence in Early Diagnosis of Alzheimer’s Disease von Schipke, C.G., Peters, O., Heuser, I., Grimmer, T., Sabbagh, M.N., Sabri, O., Hock, C., Kunz, M., Kuhlmann, J., Reininger, C., Blankenburg, M.

Volltext

Both early and late cognitive dysfunction affects the electroencephalogram in Parkinson's disease von Caviness, J.N, Hentz, J.G, Evidente, V.G, Driver-Dunckley, E, Samanta, J, Mahant, P, Connor, D.J, Sabbagh, M.N, Shill, H.A, Adler, C.H

Volltext

Alzheimer’s Disease Drug Development Pipeline 2020 von Sabbagh, Marwan N.

Volltext

Florbetapir F 18 amyloid PET and 36-month cognitive decline:a prospective multicenter study von Doraiswamy, P M, Sperling, R A, Johnson, K, Reiman, E M, Wong, T Z, Sabbagh, M N, Sadowsky, C H, Fleisher, A S, Carpenter, A, Joshi, A D, Lu, M, Grundman, M, Mintun, M A, Skovronsky, D M, Pontecorvo, M J

Volltext

Examining the Role of Microbiota in Emotional Behavior: Antibiotic Treatment Exacerbates Anxiety in High Anxiety-Prone Male Rats von Glover, M.E., Cohen, J.L., Singer, J.R., Sabbagh, M.N., Rainville, J.R., Hyland, M.T., Morrow, C.D., Weaver, C.T., Hodes, G.E., Kerman, Ilan A., Clinton, S.M.

Volltext

Cerebrovascular risk factors and preclinical memory decline in healthy APOE ε4 homozygotes von CASELLI, R. J, DUECK, A. C, RADEMAKERS, R, FINDLEY, S, REIMAN, E. M, LOCKE, D. E. C, SABBAGH, M. N, AHERN, G. L, RAPCSAK, S. Z, BAXTER, L. C, YAARI, R, WOODRUFF, B. K, HOFFMAN-SNYDER, C

Volltext

Cholinergic dysfunction in diseases with Lewy bodies von TIRABOSCHI, P, HANSEN, L. A, ALFORD, M, SABBAGH, M. N, SCHOOS, B, MASLIAH, E, THAL, L. J, COREY-BLOOM, J

Volltext

Consequences of Aberrant Insulin Regulation in the Brain: Can Treating Diabetes be Effective for Alzheimers Disease von Arab, L, Sadeghi, R, Walker, D G, Lue, L-F, Sabbagh, M N

Volltext

Functional Ability Correlates with Cognitive Impairment in Parkinson’s Disease and Alzheimer’s Disease von Sabbagh, M.N., Lahti, T., Connor, D.J., Caviness, J.N., Shill, H., Vedders, L., Mahant, P., Samanta, J., Burns, R.S., Evidente, V.G.H., Driver-Dunckley, E., Reisberg, B., Bircea, S., Adler, C.H.

Volltext

Is the functional decline of Parkinson's disease similar to the functional decline of Alzheimer's disease? von Sabbagh, M.N., Silverberg, N., Bircea, S., Majeed, B., Samant, S., Caviness, J.N., Reisberg, B., Adler, C.H.

Volltext

E4 allele dosage does not predict cholinergic activity or synapse loss in Alzheimer's disease von COREY-BLOOM, J, TIRABOSCHI, P, HANSEN, L. A, ALFORD, M, SCHOOS, B, SABBAGH, M. N, MASLIAH, E, THAL, L. J

Volltext

A blood-based signature of cerebrospinal fluid A beta(1-42) status von Fung, B.J., Aisen, P., Petersen, R., Trojanowki, J.Q., Toga, A.W., Green, R.C., Quinn, J., Silbert, L., Lind, B., Carter, R., Dolen, S., Schneider, L.S., Pawluczyk, S., Beccera, M., Fleisher, A., Heidebrink, J.L., Lord, J.L., Chowdhury, M., Ances, B., Carroll, M., Mintun, M.A., Schneider, S., Geldmacher, D., Natelson Love, M., deToledo-Morrell, L., Greig, M.T., Albert, M., D'Agostino, D., Kielb, S., Galvin, J.E., Leon, M.J. de, Oates, E., Conrad, G., Martin, K., Brand, C., McAdams-Ortiz, C., Mathews, D., Brooks, W.M., Tingus, K., Silverman, D.H.S., Parftt, F., Kendall, T., Johnson, H., Brosch, J.R., Dyck, .H. van, Carson, R.E., MacAvoy, M.G., Bergman, H., Stefanovic, B., Assaly, M., Finger, E., Pasternack, S., Rachisky, I., Munic, D., Bonakdarpour, B., Kerwin, D., Johnson, N., Reynolds, B., Lane, B., Kowall, N., Killiany, R., Johnson, P.L., Lerner, A., Ogrocki, P., Fatica, P., Olichney, J., Tariot, P., Burke, A., Reeder, S., Bates, V., Scharre, D.W., Celmins, D., Brown, A.D., Pearlson, G.D., Hynes, M.L., Williamson, J.D., Garg, P., Watkins, F., Tremont, G., Correia, S., Rosen, H.J., Perry, D., Spicer, K., Bachman, D., Chaing, G., Lin, M., Ravdin, L., Nho, K., Shaw, L., Kastsenmueller, G., Arnold, M., Wishart, D., Wurtz, P., Han, X., Fiehn, O., Thiele, I., Meikle, P., Jia, W., Black, C., Plassman, B.

Volltext bestellen

Erratum: Impact of Beta-Amyloid-Specific Florbetaben PET Imaging on Confidence in Early Diagnosis of Alzheimer’s Disease von Schipke, C.G., Peters, O., Heuser, I., Grimmer, T., Sabbagh, M.N., Sabri, O., Hock, C., Kunz, M., Kuhlmann, J., Reininger, C.

Volltext bestellen

Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study von Doraiswamy, P.M, Sperling, R.A, Johnson, K, Reiman, E.M, Wong, T.Z, Sabbagh, M.N, Sadowsky, C.H, Fleisher, A.S, Carpenter, A, Joshi, A.D, Lu, M, Grundman, M, Mintun, M.A, Skovronsky, D.M, Pontecorvo, M.J

Volltext